AzTrials
AzTrials

PseudarthrosisPSEUDO-CLAVNCT07414654

Descriptive Single-center Retrospective Study of a Series of Cases of Clavicle Pseudarthrosis: Epidemiology, Surgical Management, and Functional Outcomes

An observational study of Pseudarthrosis and Clavicle Fracture, run by University Hospital, Brest at 1 site in France.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

1. Study identification Study title: PSEUDO-CLAV - Single-center retrospective descriptive study of clavicle nonunion (pseudarthrosis): epidemiology, surgical management, and functional outcomes PSEUDO-clav_Notice non oppositi… Study type: Observational study (retrospective, single-center) using existing medical… Read more about this study

Who is it for?
Ages 18 years and older
How many people
30 participants
Where
1 siteFrance
Study dates
1 Jan 2026to 30 Sep 2026
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Retrospective, single-center study including adults (≥18 years) treated at CHU de Brest who underwent surgical management of clavicle nonunion (pseudarthrosis), aseptic or septic, between 01/01/2000 and 31/12/2024. Eligible cases have documented clinical and radiographic nonunion and sufficient perioperative records and imaging to assess outcomes. Patients who object to the reuse of their data, are under legal protection, are <18 years old, have congenital or pathologic pseudarthrosis, or were managed without surgery are not included.

Who may be able to join

  • Setting \& period: Managed at CHU de Brest (Orthopaedics-Traumatology) and operated for clavicle nonunion between 01/01/2000 and 31/12/2024.
  • Age: ≥ 18 years at the time of the index nonunion surgery.
  • Diagnosis: Clavicle pseudarthrosis (nonunion) documented in the record, defined as no clinical and radiographic union ≥6 months after the initial fracture, or radiographic signs of nonunion (e.g., gap, no bridging callus, sclerotic ends) with compatible symptoms.
  • Index treatment: Surgical management of the pseudarthrosis (e.g., osteosynthesis with/without bone graft, vascularized graft, other reconstructive technique).
  • Minimum data available: Pre- and/or peri-operative imaging confirming nonunion and at least one postoperative clinical and/or radiographic assessment (any timing).
  • Scope: Aseptic and/or septic clavicle nonunions are eligible.

Who cannot join

  • Legal protection: Adults under legal protection (sauvegarde de justice/curatelle/tutelle).
  • Patient objection: Any opposition to the use of their data.
  • Age < 18 years.
  • Non-surgical management only of the nonunion (conservative treatment without surgery).
  • Acute fractures (<6 months) without nonunion criteria, or delayed union without pseudarthrosis criteria.
  • Pathologic fracture (tumor/metastasis) or congenital clavicle pseudarthrosis.
Show all 13Show fewer
  • Care outside the study period and/or outside CHU de Brest.
  • Exclusion after initial selection (screen-fail after chart review)
  • Insufficient documentation to evaluate exposure and/or the primary outcome: no usable pre- or post-op imaging and no postoperative follow-up available (immediate loss to follow-up).
  • Early death unrelated to the condition/surgery before any postoperative assessment.
  • Unclassifiable infection status: suspected infection without microbiologic confirmation and without a clear therapeutic strategy, preventing classification as septic vs aseptic.
  • Major ipsilateral concomitant trauma making functional scores uninterpretable (e.g., severe brachial plexus injury, major scapulothoracic stiffness, recent shoulder arthroplasty).
  • Unresolved duplicates/inconsistent identifiers (same patient-same clavicle).

Trial locations and contacts

1 site in 1 country.

France1 site
  • Chu Brest

    Brest, 29200

Other trials in France

About this study

  1. Study identification Study title: PSEUDO-CLAV - Single-center retrospective descriptive study of clavicle nonunion (pseudarthrosis): epidemiology, surgical management, and functional outcomes PSEUDO-clav_Notice non oppositi… Study type: Observational study (retrospective, single-center) using existing medical records and imaging Study sponsor / data controller: CHU de Brest Scientific lead (principal investigator): Dr Agathe YVINOU (Orthopaedic \& Trauma Surgery, CHU de Brest) Data Protection Officer (DPO) contact: protection.donnees@chu-brest.fr
  2. Why is this study being done? A clavicle nonunion (pseudarthrosis) is when a broken collarbone does not heal as expected and may cause pain, reduced shoulder function, and lower quality of life. Surgery is often used, but because this condition is uncommon, the investigators want to better understand: who is affected, which surgical strategies are used, how often the bone heals after surgery, what functional recovery and complications look like in real-life practice.
  3. Goal of the study (use/keep this "fill-in" format) The goal of this observational study is to describe clavicle nonunion cases treated surgically at CHU de Brest and to estimate how often the clavicle heals after surgery, using information already collected during routine care. The main questions it aims to answer are: How often does the clavicle heal ("consolidate") after surgery? Main measure: union rate at ~6 months after surgery (assessment window approximately 4-8 months). PSEUDO-clav_Protocole_scientifi… How do patients recover in terms of function and symptoms, and what complications occur? Examples: shoulder function scores (Constant and/or DASH), pain, return to work/sport, complications and re-operations. PSEUDO-clav_Protocole_scientifi… If there is a comparison group (optional wording): Researchers may compare different surgical strategies (for example, plate fixation alone vs. plate fixation plus bone graft, and other techniques when used) to explore whether results differ for healing, recovery, or complications. PSEUDO-clav_Protocole_scientifi…
  4. Who may be included? (participant population) This study may include adults who: were treated at CHU de Brest, and had surgery for clavicle nonunion between January 1, 2000 and December 31, 2024, and were 18 years or older at the time of the nonunion surgery, and have enough information in the medical record/imaging to evaluate outcomes. PSEUDO-clav_Protocole_scientifi… Estimated number of participants: up to about 30 cases in this center (because the condition is rare). PSEUDO-clav_Protocole_scientifi…
  5. What will participants have to do? Nothing extra. This study: uses existing information already in the medical record and imaging systems, involves no additional visits, no extra tests, and no change to treatment, and does not require direct contact with patients.
  6. What information will be used? Information may include (examples): medical history related to the injury and health conditions, details of the surgery (type of fixation, whether a bone graft was used), lab results (including microbiology if relevant), radiology/imaging reports and images, follow-up notes about pain, function, healing, complications, and re-operations.
  7. Risks and benefits Risks to for the patients : Since no new procedures are done, the main risk is related to privacy/confidentiality of data. The study team puts protections in place to reduce this risk (see below). Benefits: the patients should not expect a direct personal benefit, because care is not changed. Results may help improve understanding of clavicle nonunion surgery, follow-up practices, and future care decisions.
  8. How will privacy be protected? Data used for analysis will be pseudonymized (coded). Name and first name are not included in the research dataset. Only authorized members of the research team can access the data, using secure access (e.g., password-protected files and restricted hospital systems). Study results will be presented as grouped data, so individuals cannot be identified in publications or conference presentations. Data retention: research data are kept and archived for a limited duration (e.g., up to 5 years after the end of the study, per the study documentation).
  9. Voluntary nature and patient's rights

Because this is a retrospective study using existing records, participation is based on non-opposition (opt-out). The patient can:

Read more

object to the use of data for this study, and request access, correction, or limitation of processing as permitted by data protection rules.

How to object (opt out) of PSEUDO-CLAV:

Email the DPO: protection.donnees@chu-brest.fr, or use the CHU Brest transparency portal (as listed in the notice), or contact the study scientific lead, or write to CHU Brest (address listed in the notice). Choosing not to participate will not affect patient's medical care now or in the future

Read the detailed description

Clavicle nonunion (pseudarthrosis) is an uncommon but clinically important complication of clavicle fracture that may lead to persistent pain, limitation of shoulder function, prolonged work disability, and impaired quality of life. Surgical repair is frequently proposed, most commonly using plate fixation with or without bone grafting. However, because the condition is relatively rare, available evidence is largely based on retrospective series and practice varies regarding key technical decisions (e.g., when to add bone graft, how to manage bone defects or loss of length, and how to approach septic versus aseptic nonunion). The PSEUDO-CLAV study has been designed to describe "real-world" management in a single tertiary center and to estimate healing and recovery outcomes after surgical treatment, using routinely collected data.

Overall design and setting PSEUDO-CLAV is a single-center, retrospective, observational cohort/case-series study conducted in the Orthopaedic and Trauma Surgery Department at CHU de Brest. The study reuses data generated during routine care and does not introduce additional visits, tests, or changes in management.

The study period covers patients surgically treated for clavicle nonunion between 01 January 2000 and 31 December 2024, chosen to ensure adequate follow-up for outcome assessment at the time of analysis. Approximately 30 cases are expected based on local incidence and feasibility estimates.

The study scope includes aseptic and septic clavicle nonunions treated surgically, reflecting the full spectrum of cases managed at the center.

Data sources and study procedures (no additional patient burden)

All data originate from the care pathway and are extracted from routine clinical systems, including:

medical records (history, comorbidities, perioperative and follow-up documentation), operative reports and perioperative documentation (surgical strategy and intraoperative details), imaging and radiology systems (e.g., radiographs and CT where available), and laboratory/microbiology results when relevant (including samples collected as part of standard care).

No participant is asked to perform additional tasks. There is no direct intervention and typically no direct contact for study purposes, because the project is based on reuse of existing information.

Key clinical concepts assessed

The dataset is structured to capture the patient journey from the initial fracture through nonunion diagnosis and surgical repair, with an emphasis on variables that may plausibly influence healing and recovery. Examples of routinely captured domains include:

baseline patient characteristics (e.g., age/sex, relevant comorbidities and treatments that may affect bone healing), features of the initial fracture and prior management (including previous procedures on the same clavicle), preoperative nonunion characterization (clinical status, radiographic appearance, and any measurable bone defect), infection work-up and classification when suspected (clinical signs, inflammatory markers, microbiology, and operative sampling), surgical strategy at index nonunion surgery (type of osteosynthesis, approach, debridement, restoration of length, graft type when used, and perioperative antibiotics), and follow-up information from routine visits (pain, functional scores when documented, range of motion, return to work/sport, imaging findings, complications, and any re-operations).

Outcome assessment approach (as captured in routine care) Healing is assessed using clinical and radiographic information as documented in the medical record and imaging archive. Functional outcomes are assessed using validated shoulder outcome measures when available in the chart (e.g., Constant and/or DASH), alongside other clinically relevant elements routinely recorded in follow-up (pain scores, range of motion, return to activity, and patient satisfaction). Complications are collected and categorized as early and late events, and re-interventions are documented with indication and timing.

Because follow-up schedules may vary over the long inclusion period, the protocol defines pragmatic time windows to harmonize assessment-particularly around the standard post-operative checkpoints used in routine practice (e.g., early postoperative review, intermediate visits, and the evaluation around six months).

Data management, quality control, and bias mitigation

To reduce information bias inherent in retrospective studies, the protocol specifies:

predefined operational definitions (e.g., for nonunion and for outcome assessment), a structured case report form / data dictionary approach for consistent abstraction, double review of a random sample (≥10%) of records/imaging to check data quality and resolve discrepancies, and transparent accounting of case selection (e.g., documenting exclusions and incomplete follow-up where applicable).

The study acknowledges key methodological limitations (retrospective design, small sample size, monocentric practice patterns, temporal evolution of implants/techniques across 2000-2024) and addresses them primarily through careful description, stratified/exploratory analyses, and explicit discussion of generalizability.

Statistical analysis plan (high level)

Analyses are primarily descriptive and exploratory, appropriate for the expected sample size. The protocol plans:

descriptive statistics for baseline characteristics and management patterns, estimation of proportions (e.g., healing rate) with 95% confidence intervals, time-to-event methods for time to documented healing (e.g., Kaplan-Meier; exploratory Cox modeling), exploratory group comparisons using tests suited to small samples (e.g., Fisher's exact test for categorical data; Mann-Whitney or t-test for continuous data depending on distribution), and exploratory multivariable modeling for selected outcomes where feasible (e.g., Cox for time to healing; linear regression for functional scores), interpreted cautiously given sample size.

Analyses are conducted locally using R (≥4.3), with verification steps in Python where helpful for cross-checking key results.

Ethics, privacy, and legal basis PSEUDO-CLAV is conducted under a framework for reuse of health data for research, consistent with MR004 as documented in the protocol.

Data protection measures include:

extraction limited to variables necessary for the study (data minimization), pseudonymization of the research dataset (no direct identifiers in the analysis file), restricted access on secure CHU infrastructure (password-protected study files; controlled access to linkage information when needed for information/opt-out handling), no external transfer outside CHU Brest except via approved secure internal mechanisms if required, and dissemination only in aggregated, non-identifying form. As this is a retrospective reuse of data, patients are informed through the center's information pathway and have the right to object (opt out / non-opposition framework); a minimum delay between information and analysis is planned to allow exercise of this right. The DPO contact point is provided for privacy-related questions and objections.

Expected impact and dissemination By providing an exhaustive description of surgically treated clavicle nonunion cases in this center-including operative strategies, complications, re-interventions, and functional recovery-PSEUDO-CLAV aims to support local practice improvement (e.g., clarifying when grafting is used, harmonizing follow-up windows, and informing prevention of reoperation). The protocol anticipates dissemination through scientific communication and publication, with results reported in a manner that does not permit identification of individuals.

Timeline (planned) The protocol outlines a staged process including patient information/non-opposition handling, retrospective data abstraction from records and imaging, database lock, analysis, and reporting, with planned archival and retention consistent with institutional requirements.

Medical subject headings
Pseudarthrosis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT07414654
Study groupRoleWhat they receive
Adults (≥18) surgically treated for clavicle nonunion at CHU Brest (2000-2024)Retrospective single-center cohort of adults who underwent surgery for clavicle nonunion (pseudarthrosis) at CHU de Brest between 01/01/2000 and 31/12/2024. Interventions of interest include nonunion revision surgery (e.g., plate fixation ± bone graft and related techniques) performed as part of routine care; outcomes assessed from existing records and imaging.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Clavicle union (consolidation) at 6 months after index nonunion surgery

    Binary outcome (Yes/No): whether the clavicle nonunion has consolidated at ~6 months (T6) after the index surgery for clavicle pseudarthrosis, using a predefined assessment window of 4-8 months. Consolidation is defined clinically and radiographically based on routine follow-up documentation and imaging (e.g., post-operative visits around T+6 weeks, T+3-4 months, and T+6 months with recorded clinical/radiographic consolidation).

    Measured: 2000 - 2024

Secondary outcomes (9)
  1. Time to first documented clavicle union (consolidation)

    Time from index nonunion surgery to the first clinical and/or radiographic evidence of union recorded in the chart/imaging archive (expressed in days or weeks). Determined from routine follow-up visits and imaging; includes censoring when union is not documented by last follow-up.

    Measured: 2000 - 2024

  2. Shoulder range of motion over follow-up

    Active shoulder mobility documented in routine follow-up reported as degrees as recorded in the chart, including last follow-up when available.

    Measured: 2000 - 2024

  3. Return to activities (yes/no)

    Return to sport/activities recorded in the medical file:

    Whether return occurred (yes/no)

    Measured: 2000 - 2024

  4. Return to sports/activities (time to return)

    time to return (typically captured in weeks) when documented.

    Measured: 2000 - 2024

  5. Return to work (yes/no)

    Return to work recorded in the medical file whether return occurred (yes/no)

    Measured: 2000-2024

  6. Return to work (time to return)

    Return to work recorded in the medical file time to return (typically captured in weeks) when documented.

    Measured: 2000-2024

  7. Patient satisfaction at follow-up

    Patient satisfaction recorded during follow-up, captured as yes/no, including last follow-up.

    Measured: 2000 - 2024

  8. Early postoperative complications

    Occurrence of complications after index surgery, categorized as early if ≤30 days: e.g., hematoma, superficial/deep infection, wound dehiscence, complex regional pain syndrome.

    Reported as type and frequency based on routine documentation.

    Measured: 2000 - 2024

  9. Late Postoperative Complications

    Late: e.g., implant failure, persistent nonunion, secondary septic nonunion, stiffness.

    Reported as type and frequency based on routine documentation.

    Measured: 2000-2024

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Feb 2026
  2. Study start1 Jan 2026
  3. Primary completion30 Sep 2026 (estimated)
  4. Study completion30 Sep 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Retrospective
Enrolment
30 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07414654
Sponsor's protocol ID
29BRC25.0396 - PSEUDO-CLAV
Acronym
PSEUDO-CLAV
Status last verified
Jan 2026
First submitted
9 Jan 2026
Last updated
17 Feb 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: All collected data that underlie results in a publication

Questions about this trial

What is this clinical trial studying?

An observational study of Pseudarthrosis and Clavicle Fracture, run by University Hospital, Brest at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 13 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 17 Feb 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Clavicle union (consolidation) at 6 months after index nonunion surgery (time frame: 2000 - 2024). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Feb 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in